Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Microvascular deterioration: implications for reperfusion.

T Fukuyama, B E Sobel, R Roberts

    Cardiovascular Research
    |May 1, 1984
    PubMed
    Summary

    Reperfusion after heart attack causes bleeding and "no-reflow" within hours. Myocardial hemorrhage develops before "no-reflow," suggesting it contributes to this damaging condition.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Biomarkers, surrogates, and evaluation of therapeutic agents: a proposed solution.

    Coronary artery disease·1999
    Same author

    The potential influence of insulin and plasminogen activator inhibitor type 1 on the formation of vulnerable atherosclerotic plaques associated with type 2 diabetes.

    Proceedings of the Association of American Physicians·1999
    Same author

    Differences between activation thresholds for platelet P-selectin glycoprotein IIb-IIIa expression and their clinical implications.

    Thrombosis research·1999
    Same author

    Insulin resistance and thrombosis: a cardiologist's view.

    The American journal of cardiology·1999
    Same author

    TNF-alpha and insulin, alone and synergistically, induce plasminogen activator inhibitor-1 expression in adipocytes.

    The American journal of physiology·1999
    Same author

    Cardiovascular consequences of polycystic ovary syndrome.

    Endocrinology and metabolism clinics of North America·1999

    Area of Science:

    • Cardiovascular Research
    • Myocardial Infarction
    • Ischemia-Reperfusion Injury

    Background:

    • Reperfusion therapy for acute myocardial injury is time-sensitive.
    • Myocardial hemorrhage and "no-reflow" phenomenon limit reperfusion benefits.
    • Understanding the temporal relationship between ischemia duration and these complications is crucial.

    Purpose of the Study:

    • To determine the temporal profile of reperfusion-induced myocardial hemorrhage and "no-reflow".
    • To compare hemorrhage and flow in relation to preceding ischemia duration.
    • To investigate the role of hemorrhage in the "no-reflow" phenomenon.

    Main Methods:

    • 51 dogs underwent coronary occlusion for 1-7 hours followed by reperfusion.
    • Regional myocardial hemorrhage assessed using Cr-51-RBC.
    • Regional blood flow assessed using labeled microspheres.
    • Histology confirmed hemorrhage; lissamine dye outlined perfusion defects.

    Main Results:

    • Myocardial hemorrhage occurred in the endocardium after 3 hours and epicardium after 5 hours of ischemia.
    • Regional flow decreased by 50% after 7 hours of ischemia prior to reperfusion.
    • Hemorrhage was observed earlier than the "no-reflow" phenomenon.

    Conclusions:

    • Microvascular damage severity is dependent on ischemia duration.
    • Subendocardial hemorrhage is evident earliest.
    • Blood extravasation (hemorrhage) may contribute to the "no-reflow" phenomenon.
    • Adjunctive therapies to delay microvascular damage could extend therapeutic windows.

    Related Experiment Videos